What is Suzuken Co., Ltd. (SZUKF)?

Suzuken Co., Ltd. (SZUKF) is a stock in the Healthcare sector, Medical - Distribution industry. View full analysis on Stocks360.

What is the current price of SZUKF?

The current price of SZUKF is $17.36. Prices are updated in real time on Stocks360.

What is SZUKF's price-to-earnings (PE) ratio?

SZUKF's trailing twelve-month PE ratio is 11.03, based on current price and earnings per share data available on Stocks360.

What is SZUKF's market capitalization?

SZUKF's market capitalization is $2,348,378,896.00, placing it in the mid-cap tier.

Does SZUKF pay a dividend?

Yes. SZUKF has a trailing twelve-month dividend yield of 0.04%. Dividend data is sourced from financial market providers and displayed on Stocks360.

Suzuken Co., Ltd. (SZUKF)

Stock analysis · OTC · Healthcare · Medical - Distribution

$17.36

Market Cap

$2.35B

PE (TTM)

11.03

EPS (TTM)

N/A

Dividend Yield

3.67%

Beta

0.23

Day Range

$17.36 – $17.36

52-wk Range

$15.01 – $17.36

Avg Volume

N/A

Volume

11.00K

Suzuken Co., Ltd. (SZUKF) is a publicly traded company in the Healthcare sector. Latest price: $17.36. Market cap $2.35B. Trailing PE 11.03. Dividend yield 3.67%. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

You have viewed 4 SEO analysis pages

Unlock saved watchlists, personalized setups, and referral credits with a free Stocks360 account.

Continue with free signup

1-Year Price

2025-10-31 · $15.15 2026-10-26 · $17.36 (+14.59%)

Earnings

Most Recent

Aug 7, 2026

EPS $0.15 vs est. $0.22

Missed by $0.07

Next Earnings

Nov 12, 2026

EPS estimate $0.33

Proprietary Signals

Signal snapshot temporarily unavailable.

About Suzuken Co., Ltd.

Suzuken Co., Ltd., along with its affiliated companies, operates primarily as a global wholesaler of pharmaceutical products, with a strong presence both in Japan and internationally. The company's diverse activities are structured into four main divisions: Pharmaceutical Distribution, Pharmaceutical Manufacturing, Pharmacy Services, and Healthcare-Related Services. The Pharmaceutical Distribution segment focuses on sourcing a wide array of items, including prescription medications, diagnostic substances, various medical devices and supplies, and other health-focused goods directly from manufacturers. These products are then supplied to medical facilities and pharmacies. In its Pharmaceutical Manufacturing division, Suzuken engages in the research, development, production, and marketing of ethical pharmaceuticals and diagnostic tools, with a particular emphasis on treatments for diabetes and kidney diseases. Through its Pharmacy Services segment, the company provides support via community pharmacists, while also striving to optimize the operations of local pharmacies and offering essential educational assistance. Finally, the Healthcare-Related Services division offers a broad spe…

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	11.03×
P/S (TTM)	0.16×
P/B	0.97×
PEG	0.47×
P/FCF (TTM)	0.00×
EV / EBITDA	4.75×
EV / Sales	0.12×
Earnings Yield	9.36%
Free Cash Flow Yield	0.00%
Dividend Yield	3.67%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$307.98B
Revenue (TTM)	$2.52T
Net Income (TTM)	$37.92B
Free Cash Flow (TTM)	$29.84M
Net Debt	-$97.04B
Working Capital	$164.86B
Gross Margin	7.63%
Operating Margin	1.39%
Net Margin	1.50%
Return on Equity	9.19%
Return on Invested Capital	5.62%